Section 7 AAC 27.007 - Reporting by laboratories(a) An infectious agent listed in this subsection constitutes a public health emergency requiring immediate reporting. A public, private, military, hospital, or other laboratory performing serologic, immunologic, microscopic, molecular, biochemical, or culture examinations or tests in this state or on samples obtained within this state shall immediately report evidence of human infection caused by the following agents by telephone directly to a public health agent in the department when the infectious agent is identified or suspected by the laboratory. The following infectious agents shall be reported under this section: (3)Burkholderia pseudomailei;(4)Clostridium botulinum or botulinum toxin;(5)Corynebacterium diphtheriae;(6)Francisella tularensis;(7) hemorrhagic fever viruses;(8) influenza virus, suspected novel strains;(9) Middle East Respiratory Syndrome (MERS) coronavirus;(10)Neisseria meningitidis;(13) rubella (measles) virus;(14) rubeola (measles) virus;(15) Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), suspected novel strains;(16) variola (smallpox) virus;(b) In addition to the immediate reporting requirements of (a) of this section, a public, private, military, hospital, or other laboratory performing serologic, immunologic, microscopic, biochemical, or cultural examinations or tests in this state or on samples obtained within this state shall report evidence of human infection caused by the following agents to the department not later than two working days after the examination or test is performed: (1) antibiotic-resistant organisms of national significance, including Candida auris and carbapenem-resistant organisms;(6)Campylobacter species;(7)Chlamydophila psittaci;(8)Chlamydia trachomatis;(10)Cryptosporidium species;(12)Diphyllobothrium species;(13) Shiga-toxin producing Escherichia coli (STEC);(14)Echinococcus species;(17)Haemophilus influenzae from normally sterile body fluid or site;(19) hepatitis A, B, C, D, or E virus; tests that shall be reported include (A) all reactive viral hepatitis screening tests and associated confirmatory test results;(B) tests used to establish the presence of hepatitis B or C viruses, including virologic, nucleic acid (DNA or RNA), or other viral toad detection test results, both detectable and undetectable; and(20) human immunodeficiency virus (HIV); tests that shall be reported include (A) all reactive HIV screening tests and associated coiifirmatoiry test results, both positive and negative, for human immunodeficiency virus infection;(B) tests used to establish the presence of human immunodeficiency virus, including serologic, virologic, nucleic acid (DNA or RNA), or other viral load detection test results, both detectable and undetectable;(C) genotype resnlts and associated HIV nucleotide sequence data; and(D) CD4+ (T4) lymphocyte counts and CD4+ (T4) percent of total lymphocytes results of any value;(24)Listeria monocytogenes;(26)Mycobacterium leprae;(27)Mycobacterium tuberculosis;(28)Neisseria gonorrhoeae;(31) Respiratory syncytial virus (RSV);(35)Streptococcus agalactiae from normally sterile body fluid or site;(36)Streptococcus pneumoniae from normally sterile body fluid or site;(37)Streptococcus pyogenes from normally sterile body fluid or site;(41) varicella virus, when associated with a death;(43)Yersinia enterocolitica or Yersinia pseudotuberculosis.(c) Each report must give (1) the date and result of the examination or test performed;(2) the name or identification code sufficient to identify the patient to the health care provider; and(3) the date of birth, address and telephone number, sex, race, and ethnicity of the patient from whom the specimen was obtained and the name and address of the health care provider for whom the examination or test was performed.(d) When acting on the basis of information received from a report made under this section, the public health agent shall first attempt to contact the health care provider for whom the examination or test was performed before contacting the patient directly.(e) A laboratory that confirms one of the pathogens in the following list shall submit isolates or aliquots of original specimens to the state public health laboratory: (1) antibiotic-resistant organisms of national significance, including Candida auris and carbapenem-resistant organisms;(5)Burkholderia pseudomallei;(6)Campylobacter species;(7)Clostridium botulinum; the laboratory shall provide a sample of the organism and, if available, a serum, stool, emesis, food, or environmental sample;(9)Corynebacteritmi diphtheriae;(10)Escherichia coli, shiga toxin-producing;(11)Francisella tularensis;(13)Haemophilus influenzae from normally sterile body fluid or site;(14)Listeria monocytogenes;(15)Mycobacterium leprae;(16)Mycobacterium tuberculosis;(17)Neisseria sonorrhoeae;(18)Neisseria meningitidis from normally sterile body fluid or site;(20) Severe Acute Respiratory Syndrome corona virus (SARS-CoV), suspected novel strains;(22)Streptococcus agalactiae from normally sterile body fluid or site;(23)Streptococcus pneumoniae from normally sterile body fluid or site;(24)Streptococcus pyogenes from normally sterile body fluid or site;(f) Upon the request of the division of the department that oversees public health, a laboratory shall submit clinical material related to an outbreak or other unusual disease not identified in this section.Eff. 8/21/74, Register 51; am 9/20/75, Register 55; am 3/28/84, Register 89; am 1/19/96, Register 137; am 2/10/99, Register 149; am 5/30/2003, Register 166; am 8/22/2003, Register 167; am 12/29/2006, Register 180; am 5/3/2007, Register 182; am 12/29/2013, Register 208, January 2014; am 11/30/2018, Register 228, January 2019; am 9/3/2023, Register 247, October 2023Authority:AS 18.05.040
AS 18.15.355
AS 18.15.362
AS 18.05.370